BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Zyga Technology, Inc. Receives FDA 510(K) Clearance for the SImmetry(TM) Sacroiliac Joint Fusion System


1/18/2011 8:27:19 AM

MINNEAPOLIS, Jan. 18, 2011 /PRNewswire/ -- Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has granted the company 510(K) clearance to market the SImmetry Sacroiliac Joint Fusion System. The SImmetry Sacroiliac Joint Fusion System is intended for treating conditions including degenerative sacroiliitis and sacroiliac joint disruptions. The SImmetry Sacroiliac Joint Fusion System consists of a range of threaded, cannulated implants and associated instrumentation. The implants are designed to transfix the sacrum and ilium, providing stability for bony fusion.

(Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO)

Sacroiliac joint dysfunction has been shown to be the source of pain for up to 30% of patients suffering from low back pain. Sacroiliac joint dysfunction can cause SI joint pain and is typically characterized by sacroiliac ligament pain, lower back pain, buttock pain, or pain in one or both legs. Patients who suffer from this condition typically receive SI Joint injections which temporarily address the problem but require long-term repeat treatments. Traditional, open fusion of the SI joint has been performed for decades but is limited in practice due to its complexity, high complication rate and generally poor outcomes.

According to Dr. Richard Kube, Chief of Orthopedic Surgery at Prairie Spine & Pain Institute in Peoria, IL, "SImmetry is a welcome addition to my practice because it gives patients suffering from sacroiliac joint dysfunction a minimally invasive surgical treatment option. The SImmetry system allows surgeons to prepare the SI joint for a true arthrodesis."

"We are very excited for this important milestone in our company. Increased awareness of SI joint disruption as a significant contributor to low back pain led us to develop a minimally invasive solution to treat this condition," said Robert Assell, President and CEO of Zyga Technology, Inc.

About Zyga Technology, Inc.

Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine. In addition to SImmetry the company is also developing the Glyder Facet Resurfacing System. Glyder is being developed as a minimally invasive technique for treating patients with facetogenic pain. Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry.

SOURCE Zyga Technology, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES